(Q44365115)

English

Assessment of adverse events during drug development: experience with temafloxacin

scientific article published on December 1, 1991

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

retrieved

2 December 2017

title

Assessment of adverse events during drug development: experience with temafloxacin (English)

1 reference

stated in

Crossref

DOI

10.1093/JAC/28.SUPPL_C.111

reference URL

https://api.crossref.org/works/10.1093/JAC/28.SUPPL_C.111

23 October 2022

1 reference

10.1093/JAC/28.SUPPL_C.111

reference URL

https://api.crossref.org/works/10.1093/JAC/28.SUPPL_C.111

retrieved

23 October 2022

author name string

S. R. Norrby

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1664824

retrieved

23 October 2022

A. G. Pernet

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1664824

retrieved

23 October 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

retrieved

2 December 2017

full work available at URL

http://academic.oup.com/jac/article-pdf/28/suppl_C/111/6936386/28-suppl_C-111.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1093/JAC/28.SUPPL_C.111

reference URL

https://api.crossref.org/works/10.1093/JAC/28.SUPPL_C.111

retrieved

23 October 2022

published in

Journal of Antimicrobial Chemotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

retrieved

2 December 2017

volume

28 Suppl C

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

retrieved

2 December 2017

page(s)

111-119

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

retrieved

2 December 2017

Identifiers

DOI

10.1093/JAC/28.SUPPL_C.111

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

retrieved

2 December 2017

PubMed publication ID

1664824

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1664824

retrieved

2 December 2017

(Q44365115)

Assessment of adverse events during drug development: experience with temafloxacin

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)